AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novel Coronavirus Treatment

1,056.142

+7.8860.75%

Number of Gainers:8

Number of Losers:11

Number of Flat:13

PE:- -

High:1,065.172

Open:1,050.472

Low:1,044.586

Close:1,048.256

Loading ...

ASX Weekly Review | Almost $60 Billion Lost in Shock Tariff Trade

Broker laments 'catastrophic negative surprise' that highlights the risks with these types of ASX shares

A trip down memory lane: How buying stocks in the Covid pandemic made me a better investor today

Tariffs on US Imports to Rise to Highest Level in Almost a Hundred Years; Jarden Research Says

MT Newswires Live

Here are the top 10 ASX 200 shares today

ASX 200 plunges as US tariffs fall-out continues

Australian Shares End Week Lower; Santos, Woodside Energy Shares Decline as Oil Prices Crash

MT Newswires Live

Australian shares fall to eight-month lows as US tariffs hit global markets

Should I buy Fisher & Paykel or ResMed shares?

ResMed Launches Home Sleep Apnea Test Across US; Shares Fall 3%

MT Newswires Live

5 ASX 200 shares rocketing higher in this month's falling market

Ansell's Tariff Exposure Looks Largest in Australian Healthcare -- Market Talk

Ansell To Fully Offset Tariff Increases Through Pricing

Friday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025

The Market Herald

BUZZ-Australia's Ansell rises on price hike plan to offset US tariffs

Inflation confirmed: Ansell pares some of Thursdays’ bloodshed as prices to rise

The Market Herald

BRIEF-Mesoblast Says Mesoblast Cell Therapy Products Not Subject To U.S. Tariffs

Ansell Could Face Competition While It Amends Prices -- Market Talk

Mesoblast Says Products Exempt From US Tariffs

MT Newswires Live

Australia's Ansell Will Raise U.S. Prices to Offset Tariffs -- Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7501/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":1056.142,"timestamp":1743742799957,"preClose":1048.256,"halted":0,"volume":34282781,"delay":0,"changeRate":0.007523,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":7.885986,"latestTime":"04-04 16:00:00 AEDT","open":1050.4718,"high":1065.1724,"low":1044.5863,"amount":625956453,"amplitude":0.019638,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1743984000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1743721200000,1743742800000]],"turnoverRate":0.002571,"increases":9,"decrements":12,"flats":12,"marketCap":267036464376,"floatMarketCap":220663462927.21094},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":1065.1724,"amplitude":0.019638,"preClose":1048.256,"low":1044.5863,"latestPrice":1056.142,"volume":34282781,"delay":0,"open":1050.4718,"prevYearClose":1117.913,"prevWeekClose":1031.503,"prevMonthClose":1021.93,"prevQuarterClose":1021.93,"fiveDayClose":1031.503,"twentyDayClose":1036.879,"sixtyDayClose":1130.907,"secType":"PLATE","market":"AU","turnoverRate":0.002571,"marketCap":267036464376,"floatMarketCap":220663462927.21094,"timestamp":1743742799957,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":8,"down":11,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524270151","title":"ASX Weekly Review | Almost $60 Billion Lost in Shock Tariff Trade","url":"https://stock-news.laohu8.com/highlight/detail?id=2524270151","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524270151?lang=en_us&edition=fundamental","pubTime":"2025-04-05 09:50","pubTimestamp":1743817800,"startTime":"0","endTime":"0","summary":"The Australian share market fell to its biggest loss in eight months on Friday in reaction to a sickening drop on world share markets after investors reacted to US President Donald Trump’s range of he","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/weekly-wrap-almost-60-billion-lost-shock-tariff-trade/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7503","WDS.AU","BK7142","XJO.AU","BK7119","BK7051","BK7126","BK7095","BK7049","KAR.AU","ANN.AU","BHP.AU","BK7046","XKO.AU","STO.AU","BK7016","FMG.AU","360.AU","BK7511","CBA.AU","NAB.AU","WTC.AU","AOV.AU","BK7135","NXT.AU","BK7501","RIO.AU","BK7507","ANZ.AU","MQG.AU","XAO.AU","BK7021","BRG.AU","WBC.AU","BK7129","CTT.AU","BK7043"],"gpt_icon":1},{"id":"2525222758","title":"Broker laments 'catastrophic negative surprise' that highlights the risks with these types of ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2525222758","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525222758?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:00","pubTimestamp":1743796800,"startTime":"0","endTime":"0","summary":"ASX share Opthea Limited (ASX: OPT)remains suspended from trading as the biotechcompany works to avoid insolvency.  Opthea last traded at 60 cents per share.   Last week, we learned that Opthea has de","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/05/broker-laments-catastrophic-negative-surprise-that-highlights-the-risks-with-these-types-of-asx-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7511","MSB.AU","BK7067","BK7508","CSL.AU","OPT.AU","BK4139","OPT","XJO.AU","BK7501"],"gpt_icon":0},{"id":"2525756951","title":"A trip down memory lane: How buying stocks in the Covid pandemic made me a better investor today","url":"https://stock-news.laohu8.com/highlight/detail?id=2525756951","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525756951?lang=en_us&edition=fundamental","pubTime":"2025-04-05 03:00","pubTimestamp":1743793200,"startTime":"0","endTime":"0","summary":"What has happened on the stock markets this week, both here on the ASX and on international markets, might trigger some rather unpleasant memories for investors who were around during the turmoil of t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/05/a-trip-down-memory-lane-how-buying-stocks-in-the-covid-pandemic-made-me-a-better-investor-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["WOW.AU","BK7082","BK7040","COL.AU","BK7511","BK7501"],"gpt_icon":0},{"id":"2524273512","title":"Tariffs on US Imports to Rise to Highest Level in Almost a Hundred Years; Jarden Research Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2524273512","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524273512?lang=en_us&edition=fundamental","pubTime":"2025-04-04 15:14","pubTimestamp":1743750852,"startTime":"0","endTime":"0","summary":"Tariffs on US imports are set to rise to their highest levels since the 1930s, with the weighted average expected to reach 29.4%, according to a Thursday note by Jarden Research.Jarden noted that the ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7002","TWE.AU","LU2449327464.USD","LNG","LU0368265418.SGD","LU0251131958.USD","FPH.AU","LU0122376428.USD","IE00B29SXK94.USD","WDS.AU","IE00B29SXL02.USD","LU0788109394.HKD","LU0345780950.USD","LU0170899867.USD","LU0314104364.USD","LU0345770308.USD","BK7501","WTC.AU","LU0345770993.USD","BK7016","BK7142","BK7007","XKO.AU","LU0742534661.SGD","BK7505","BK4144","LU0048573561.USD","XJO.AU","LU0630314457.HKD","LU0251142724.SGD","BK7503","BK7097","LU0345781412.USD","XAO.AU","CAR.AU"],"gpt_icon":0},{"id":"2524271494","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2524271494","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524271494?lang=en_us&edition=fundamental","pubTime":"2025-04-04 14:18","pubTimestamp":1743747483,"startTime":"0","endTime":"0","summary":"It was a calamitous end to a calamitous week for the S&P/ASX 200 Index (ASX: XJO) this Friday. The ongoing fallout from President Donald Trump's new tariffs once again smashed the ASX 200 today. The i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/04/here-are-the-top-10-asx-200-shares-today-04-april-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7028","MTS.AU","LYC.AU","BK7501","BK7511","EDV.AU","BK7083","BK7126","BK7507","SHL.AU","XJO.AU","WOW.AU","BOE.AU","BK7506","BK7095","BK7124","BK7040","CMM.AU","COL.AU","BK7082","ANN.AU","BK7104","GOR.AU"],"gpt_icon":1},{"id":"2524279082","title":"ASX 200 plunges as US tariffs fall-out continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2524279082","media":"MotleyFool","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524279082?lang=en_us&edition=fundamental","pubTime":"2025-04-04 14:00","pubTimestamp":1743746431,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index  plummeted by 191.9 points or 2.44% on Friday to finish the week at 7,667.8 points.Uncertainty about how the newly announced reciprocal US tariffs will impact ASX 200 shares fuelled today's dive.Based on closing values, today's market rout has pushed the ASX 200 into an official market correction.A market correction is defined as a major index falling 10% from its most recent peak.The ASX 200 narrowly avoided a correction last month after it fell 9.43% from its record high on 14 February to a trough on 13 March.The fall saw several blue-chip sharestrading at multi-year lows, including Fortescue Ltd  and CSL Ltd .The ASX 200 began a rebound on 14 March, but this week's US tariffs news has brought that undone.The ASX 200 closed down 10.38% from its 14 February high today.Today, we heard from more companies about the potential impact of the tariffs on their operations.ASX 200 dives into official correction as more companies reveal US tariff impact. The ASX 200 biotec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/04/asx-200-plunges-as-us-tariffs-fall-out-continues/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["AOV.AU","BK7508","CSL.AU","BK7129","FMG.AU","ANN.AU","BRG.AU","BK7067","BK7511","MSB.AU","BK7501","BK7051","BK7126","BK7507","XJO.AU","BK7119"],"gpt_icon":0},{"id":"2524227519","title":"Australian Shares End Week Lower; Santos, Woodside Energy Shares Decline as Oil Prices Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=2524227519","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524227519?lang=en_us&edition=fundamental","pubTime":"2025-04-04 13:54","pubTimestamp":1743746068,"startTime":"0","endTime":"0","summary":"Australian shares closed the week lower, as concerns persisted that Thursday's tariffs will hit economic growth, extending the global selloff in stocks.The S&P/ASX 200 Index fell 2.4% or 191.9 points ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0757428866.USD","RBA","STO.AU","BK7142","XKO.AU","LU1815336091.USD","IAG.AU","WDS.AU","ANN.AU","XJO.AU","LU2098885051.SGD","BK7126","BK7034","XAO.AU","LU1303367103.USD","BK7501","BK4137","BK7507"],"gpt_icon":0},{"id":"2524222048","title":"Australian shares fall to eight-month lows as US tariffs hit global markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2524222048","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524222048?lang=en_us&edition=fundamental","pubTime":"2025-04-04 13:46","pubTimestamp":1743745613,"startTime":"0","endTime":"0","summary":"Australian shares fall to eight-month lows as US tariffs hit global marketsEnergy stocks end down 8%Technology stocks down over 6%RBNZ monetary policy decision due April 9By Roshan Thomas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250404:nL3N3QI092:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7040","BK7501","BK7112","AMP.AU","BK7511","STO.AU","WOW.AU","BK7507","BK7142"],"gpt_icon":0},{"id":"2524278832","title":"Should I buy Fisher & Paykel or ResMed shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524278832","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524278832?lang=en_us&edition=fundamental","pubTime":"2025-04-04 11:48","pubTimestamp":1743738489,"startTime":"0","endTime":"0","summary":"Both companies are global leaders with strong track records, but when it comes to deciding which to buy today, the case for ResMed shares looks particularly compelling.Fisher & Paykel is a New Zealand-based medical device company that designs, manufactures and markets equipment used in acute and chronic respiratory care, surgical applications, and sleep apnoea treatment.The company has a presence in more than 120 countries and has built a strong reputation over decades. However, despite the quality of the business, analysts are taking a more measured view for now.Morgan Stanley currently has an equal-weight  rating on the stock with a $36.30 price target, compared to its recent share price of $31.40. That represents some upside, but the broker isn't quite ready to call it a buy.Goldman Sachs recently reaffirmed its conviction buy rating on ResMed shares with a $49.00 price target, well above the current share price of $33.82.For investors looking for growth, value, and global exposure ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/04/should-i-buy-fisher-paykel-or-resmed-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4127","LU0106831901.USD","LU2133065610.SGD","BK8004","BK4588","LU2750360641.GBP","BK4548","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU2237443622.USD","BK4516","LU0912757837.SGD","RMD.AU","IE00BZ1G4Q59.USD","RMD","LU0061475181.USD","LU0158827781.USD","LU2471134879.HKD","LU0225283273.USD","BK4534","LU1868837300.USD","LU1791807156.HKD","LU0096364046.USD","LU0742534661.SGD","LU2008162690.USD","IE00BSNM7G36.USD","LU1868836591.USD","BK4504","LU0158827948.USD","BK7501","IE00BFXG1179.USD","LU1074936037.SGD","LU1720051017.SGD","LU2237443978.SGD","LU2237438978.USD","IE0004091025.USD","BK4533","FPH.AU","BK4552","FPH.NZ","LU0314104364.USD","LU1732800096.USD","LU2471134796.USD","LU2111349929.HKD","IE0004086264.USD","LU1548497426.USD","LU0320765646.SGD","LU0048573561.USD","LU2237443465.HKD","LU1720051108.HKD"],"gpt_icon":0},{"id":"2524252792","title":"ResMed Launches Home Sleep Apnea Test Across US; Shares Fall 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524252792","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524252792?lang=en_us&edition=fundamental","pubTime":"2025-04-04 11:30","pubTimestamp":1743737426,"startTime":"0","endTime":"0","summary":"ResMed  launched its US Food and Drug Administration-cleared home sleep apnea test, NightOwl, across the US, according to a Friday statement by the company.The fingertip sensor allows individuals to test for obstructive sleep apnea at home, the statement said.Shares of the company fell nearly 3% in recent Friday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","LU0170899867.USD","LU2177674079.SGD","HBCP","LU2008162690.USD","CFA.SI","BK7501","RMD.AU","BK4548","BK4567","RMD","BK4082","BK4195","BK4588","BK4585","BK4211","BK4504"],"gpt_icon":0},{"id":"2524221382","title":"5 ASX 200 shares rocketing higher in this month's falling market","url":"https://stock-news.laohu8.com/highlight/detail?id=2524221382","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524221382?lang=en_us&edition=fundamental","pubTime":"2025-04-04 11:01","pubTimestamp":1743735666,"startTime":"0","endTime":"0","summary":"It's been a rough month for many S&P/ASX 200 Index  shares. But not all!Well, Evolution Mining Ltd  shares closed on 6 March at $6.50 and are currently trading for $7.05. That sees the Evolution Mining share price up 8.5%, racing ahead of the 4.3% one-month losses posted by the benchmark index. Westgold Resources Ltd also enjoyed a strong month, with shares leaping from $2.53 four weeks ago to $2.84 in afternoon trade today. This puts the Westgold share price up 12.3% in a month. And you won't hear investors complaining about Gold Road Resources Ltd  either. Gold Road shares have surged from $2.58 on 6 March to $3.04 today, up 17.8%. And the best performing ASX 200 share on my list over this past turbu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/04/5-asx-200-shares-rocketing-higher-in-this-months-falling-market/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["RRL.AU","BK7506","BK7511","EVN.AU","COL.AU","GOR.AU","BK7501","WGX.AU","BK7104","BK7082","BK7040","WOW.AU","XJO.AU"],"gpt_icon":0},{"id":"2524223333","title":"Ansell's Tariff Exposure Looks Largest in Australian Healthcare -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2524223333","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524223333?lang=en_us&edition=fundamental","pubTime":"2025-04-04 10:57","pubTimestamp":1743735420,"startTime":"0","endTime":"0","summary":"0257 GMT - Ansell is likely to be the Australian healthcare stock that is most exposed to the impact of U.S. tariffs, Citi analysts write in a note. They acknowledge that breath-tech maker ResMed and medical-tech provider Nanosonics are probably impacted, given their manufacturing footprints, but not to the same extent as Ansell. The personal-protective equipment maker sources a majority of its products from Malaysia and Sri Lanka, both of which are among the countries hardest hit by tariffs, generating more than 40% of its revenue from the U.S. The exclusion of pharmaceuticals from tariffs is a relief for vaccine maker CSL, they add. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","BK4137","BK7126","ANN.AU","BK7501"],"gpt_icon":0},{"id":"2524476652","title":"Ansell To Fully Offset Tariff Increases Through Pricing","url":"https://stock-news.laohu8.com/highlight/detail?id=2524476652","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524476652?lang=en_us&edition=fundamental","pubTime":"2025-04-04 10:06","pubTimestamp":1743732372,"startTime":"0","endTime":"0","summary":"April 4 (Reuters) - Ansell Ltd ::*FULLY OFFSET TARIFF INCREASES THROUGH PRICING*MAINTAINS FY25 ADJUSTED EPS GUIDANCE AT US118 TO US128*Further company coverage: ANN.AX* ((Reuters.Briefs@thomsonreuters","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250404:nRSDbgfTmb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","ANN.AU","BK7501"],"gpt_icon":0},{"id":"2524478612","title":"Friday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524478612","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524478612?lang=en_us&edition=fundamental","pubTime":"2025-04-04 09:57","pubTimestamp":1743731820,"startTime":"0","endTime":"0","summary":"The ASX has been down 1.5% at 7,739 points this morning.There’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.Staples and Health Care are the only sectors in positive territory so far.In company news, Mesoblast  has been among the most watched on HotCopper forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.Orthocell  has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.And, finally, Bellevue Gold  has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”。The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/fridays-hotcopper-trends-mesoblast-dodges-tariffs-orthocells-fda-tick-april-4-2025-2025-04-04/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["OCC.AU","BK7508","BK7067","BK4139","MESO","MSB.AU","BK7501","BGL.AU","BK7104"],"gpt_icon":0},{"id":"2524490402","title":"BUZZ-Australia's Ansell rises on price hike plan to offset US tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2524490402","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524490402?lang=en_us&edition=fundamental","pubTime":"2025-04-04 09:07","pubTimestamp":1743728858,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Ansell rises on price hike plan to offset US tariffs** Ansell ANN.AX rises as much as 4.9% to A$30.770; on track to snap two consecutive sessions of losses** Personal protection equipment maker plans to fully offset tariff increases on products imported into U.S. through pricing** Maintains outlook range for FY25 adjusted EPS at 118-128 U.S. cents** Stock set to end week in the red after two weeks of gains** ANN sheds 9.7% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250404:nL6N3QI00Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","ANN.AU","BK7126"],"gpt_icon":0},{"id":"2524648246","title":"Inflation confirmed: Ansell pares some of Thursdays’ bloodshed as prices to rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2524648246","media":"The Market Herald","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524648246?lang=en_us&edition=fundamental","pubTime":"2025-04-04 08:27","pubTimestamp":1743726420,"startTime":"0","endTime":"0","summary":"Ansell  has today confirmed U.S. consumers will bear the brunt of Trump tariffs with the company now planning to raise its U.S. prices.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.Ansell was slaughtered on Thursday as the market made its assessment of the company’s exposure to the U.S. tariff regime; significant for one reason.Ansell manufactures a lot of its products in Malaysia and Sri Lanka, as well as other Asian and Southeast Asian jurisdictions – including China – which received higher tariff rates than many Western counterparts.In that way, Ansell shares are down -14% MoM and down nearly -10% YTD, cemented by Thursday’s sell-off. .“It is worth noting the vast majority of manufacturing in our industry is conducted in Asian countries now subject to US tariffs, and US industry manufacturing capacity for comparable hand and body protection products is negligible,” Ansell wrote","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/inflation-confirmed-ansell-pares-some-of-thursdays-bloodshed-as-prices-to-rise-2025-04-04/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7501","ANN.AU","BK7126"],"gpt_icon":0},{"id":"2524124544","title":"BRIEF-Mesoblast Says Mesoblast Cell Therapy Products Not Subject To U.S. Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2524124544","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524124544?lang=en_us&edition=fundamental","pubTime":"2025-04-04 08:15","pubTimestamp":1743725743,"startTime":"0","endTime":"0","summary":"BRIEF-Mesoblast Says Mesoblast Cell Therapy Products Not Subject To U.S. TariffsApril 4  - Mesoblast Ltd MSB.AX:MESOBLAST CELL THERAPY PRODUCTS NOT SUBJECT TO U.S. TARIFFSCELL THERAPY PRODUCTS NOT SUBJECT TO U.S. TARIFFSALLOGENEIC CELLULAR PRODUCTS, INCLUDING RYONCIL AND REVASCOR, WILL NOT BE SUBJECT TO TARIFFSFurther company coverage: MSB.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250404:nFWN3QH173:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK7501","MSB.AU","BK7508","MESO","BK7067"],"gpt_icon":0},{"id":"2524524363","title":"Ansell Could Face Competition While It Amends Prices -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2524524363","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524524363?lang=en_us&edition=fundamental","pubTime":"2025-04-04 07:40","pubTimestamp":1743723600,"startTime":"0","endTime":"0","summary":"2340 GMT - Australia's Ansell could face intensifying competition while it implements changes to its sourcing and pricing agreements, Jefferies analysts say. They tell clients in a note that it will take time for the personal-protective equipment manufacturer to implement its response to U.S. tariffs. Writing prior to Ansell's announcement that it will hike its U.S. prices to offset tariff impacts, the Jefferies analysts observe that the company has greatest pricing power in categories where it has leading market share. They also reckon that Ansell has flexibility with outsourced products to pull supply from lower-tariffed countries. Jefferies has a last-published hold rating and A$42.00 target price on the stock, which is up 3.75% at A$30.44. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","ANN.AU","BK7501"],"gpt_icon":0},{"id":"2524248874","title":"Mesoblast Says Products Exempt From US Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2524248874","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524248874?lang=en_us&edition=fundamental","pubTime":"2025-04-04 07:14","pubTimestamp":1743722066,"startTime":"0","endTime":"0","summary":"Mesoblast  said that its allogeneic cellular products will not be impacted by the US government's recently implemented tariffs on imported goods, according to a Friday filing with the Australian bourse.The company clarified that these products are derived from US donors and are classified as US-origin, making them exempt from the tariffs.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","XAO.AU","BK4139","BK7067","BK7508","XJO.AU","XKO.AU","MESO","MSB.AU"],"gpt_icon":0},{"id":"2524101402","title":"Australia's Ansell Will Raise U.S. Prices to Offset Tariffs -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2524101402","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524101402?lang=en_us&edition=fundamental","pubTime":"2025-04-04 07:04","pubTimestamp":1743721440,"startTime":"0","endTime":"0","summary":"SYDNEY--Australia's Ansell said it plans to offset the effects of higher U.S. tariffs on its personal-protective-equipment products by increasing the prices it charges its customers.The approach is the same one Ansell took when the U.S. imposed tariffs in China in 2018. Those higher costs didn't prompt Ansell to switch production to the U.S., and the company isn't looking to do so now.\"U.S. industry manufacturing capacity for comparable hand and body protection products is negligible,\" Ansell said in a market filing.Ansell makes gloves, suits and other items in 14 facilities across nine countries, as well as calling on a network of third-party suppliers. A majority of its products are made in Malaysia, Sri Lanka, Thailand, Vietnam and China.President Trump's tariffs include 24% on goods from Malaysia, 36% on Thailand, and 44% on Sri Lanka. The tariff announcement sparked a 14% drop in Ansell's shares on Thursday, making the stock the worst hit on Australia's benchmark index.About 43% o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANN.AU","BK7126","BK7501"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":139}]}}